This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tao Min - Innovator in Pharmaceutical Science
Introduction: Tao Min is an accomplished inventor based in Nanjing, China. He is currently associated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. Despite having no granted patents to his name, he is actively involved in the development of innovative pharmaceutical compositions.
Latest Patent Applications: Tao Min's latest patent applications include significant advancements in pharmaceutical formulations. One of his applications is for a pharmaceutical composition of (S)-ketorolac and its preparation method. This composition includes (S)-ketorolac or a pharmaceutically acceptable salt, a stabilizer, a pH-adjusting agent, and an excipient. The preferred dosage form is a lyophilized powder injection, which has shown optical purity of the active ingredient greater than or equal to 95% after long-term stability tests. Another application focuses on a ketorolaco derivative that boasts improved half-life and stability, enhancing efficacy while reducing toxicity. This innovation addresses common issues associated with traditional ketorolaco preparations.
Conclusion: Tao Min is a dedicated inventor making strides in the pharmaceutical field, particularly in the development of innovative drug formulations. His work has the potential to significantly impact the effectiveness and safety of non-steroidal anti-inflammatory drugs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile